eFFECTOR Therapeutics, Inc. (EFTR) Reports In-Line Q3 EPS

eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13).

For earnings history and earnings-related data on eFFECTOR Therapeutics, Inc. (EFTR) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• Deutsche Bank monitors UK auto sales as Chinese exports grow